These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1352482)

  • 1. The effect of anti-adhesion molecule antibody on the development of collagen-induced arthritis.
    Kakimoto K; Nakamura T; Ishii K; Takashi T; Iigou H; Yagita H; Okumura K; Onoue K
    Cell Immunol; 1992 Jul; 142(2):326-37. PubMed ID: 1352482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
    Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
    Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies.
    Chiocchia G; Boissier MC; Fournier C
    Eur J Immunol; 1991 Dec; 21(12):2899-905. PubMed ID: 1836185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
    Szeliga J; Hess H; Rüde E; Schmitt E; Germann T
    Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist.
    Verdrengh M; Jonsson IM; Zaether O; Bajtner E; Holmdahl R; Tarkowski A
    Ann Rheum Dis; 2002 Sep; 61(9):829-31. PubMed ID: 12176810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
    He Y; Mellon J; Apte R; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody.
    Maeda T; Saikawa I; Hotokebuchi T; Sugioka Y; Eto M; Murakami Y; Nomoto K
    Arthritis Rheum; 1994 Mar; 37(3):406-13. PubMed ID: 8129796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
    Nandakumar KS; Holmdahl R
    J Immunol Methods; 2005 Sep; 304(1-2):126-36. PubMed ID: 16125192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
    Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
    J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.
    Hutamekalin P; Saito T; Yamaki K; Mizutani N; Brand DD; Waritani T; Terato K; Yoshino S
    J Immunol Methods; 2009 Mar; 343(1):49-55. PubMed ID: 19330909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated type II collagen reactive T cells are not eliminated by in vivo anti-CD4 treatment. Implications for therapeutic approaches on autoimmune arthritis.
    Goldschmidt TJ; Andersson M; Malmström V; Holmdahl R
    Immunobiology; 1992 Apr; 184(4-5):359-71. PubMed ID: 1350565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28-deficient mice are highly resistant to collagen-induced arthritis.
    Tada Y; Nagasawa K; Ho A; Morito F; Ushiyama O; Suzuki N; Ohta H; Mak TW
    J Immunol; 1999 Jan; 162(1):203-8. PubMed ID: 9886387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen-induced arthritis--characteristics of the animal model and implications for the treatment of autoimmune disease.
    Kakimoto K
    Chin Med Sci J; 1991 Jun; 6(2):78-83. PubMed ID: 1804381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CD44 induces ICAM-1/LFA-1-independent, Ca2+, Mg(2+)-independent adhesion pathway in lymphocyte-endothelial cell interaction.
    Toyama-Sorimachi N; Miyake K; Miyasaka M
    Eur J Immunol; 1993 Feb; 23(2):439-46. PubMed ID: 7679645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule-1.
    Bullard DC; Hurley LA; Lorenzo I; Sly LM; Beaudet AL; Staite ND
    J Immunol; 1996 Oct; 157(7):3153-8. PubMed ID: 8816427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
    Yoshino S
    J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion molecule monoclonal antibodies inhibit experimental autoimmune thyroiditis.
    Metcalfe RA; Tandon N; Tamatani T; Miyasaka M; Weetman AP
    Immunology; 1993 Nov; 80(3):493-7. PubMed ID: 7904592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
    Cook AD; Braine EL; Campbell IK; Rich MJ; Hamilton JA
    Arthritis Res; 2001; 3(5):293-8. PubMed ID: 11549370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.
    Isobe M; Yagita H; Okumura K; Ihara A
    Science; 1992 Feb; 255(5048):1125-7. PubMed ID: 1347662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.